Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -30,310 | -15,143 | N/A | N/A |
| Depreciation Amortization | 823 | 667 | N/A | N/A |
| Income taxes - deferred | 8 | 10 | N/A | N/A |
| Accounts receivable | -1,638 | -237 | N/A | N/A |
| Accounts payable and accrued liabilities | 660 | 366 | N/A | N/A |
| Other Working Capital | 60,673 | 5,958 | N/A | N/A |
| Other Operating Activity | 1,586 | 371 | 0 | 0 |
| Operating Cash Flow | $31,802 | $-8,008 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,663 | -732 | N/A | N/A |
| Investing Cash Flow | $-1,663 | $-732 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 3,359 | N/A | N/A |
| Debt Repayment | -1,256 | -724 | N/A | N/A |
| Common Stock Issued | 8 | 62 | N/A | N/A |
| Other Financing Activity | 26,802 | 0 | 0 | 0 |
| Financing Cash Flow | $25,554 | $2,697 | $N/A | $N/A |
| Beginning Cash Position | 8,703 | 14,746 | N/A | N/A |
| End Cash Position | 64,396 | 8,703 | N/A | N/A |
| Net Cash Flow | $55,693 | $-6,043 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 31,802 | -8,008 | N/A | N/A |
| Capital Expenditure | -1,663 | -732 | N/A | N/A |
| Free Cash Flow | 30,139 | -8,740 | 0 | 0 |